Seoul, South Korea

Baek Il Kim


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Baek Il Kim

Introduction

Baek Il Kim, a distinguished inventor based in Seoul, South Korea, is known for his innovative contributions to the field of biotechnology. With a focus on enhancing the stability of calcium phosphate solutions, his work has potential applications in various sectors, including food and pharmaceuticals.

Latest Patents

Baek Il Kim holds a patent titled "Method for preparing aqueous solution of high-concentration calcium phosphate stable in neutral pH range." This patent discloses a method for creating an aqueous solution that maintains a high concentration of calcium phosphate without forming precipitates after neutralization. The method includes the preparation of an acidic aqueous solution using a chelating agent, followed by the addition of a calcium phosphate-based compound and a pH-adjusting agent. This innovative approach opens avenues for the use of calcium-containing products in foods, drugs, and quasi-drugs.

Career Highlights

Baek Il Kim is currently affiliated with Bioalpha Corporation, where his expertise in materials science and chemistry has significantly contributed to the company's research and development efforts. His innovative methods are instrumental in advancing the applications of calcium phosphate in various industries.

Collaborations

Throughout his career, Baek Il Kim has collaborated with talented colleagues, including Hyun Seung Ryu and Mi Young Ryu. These partnerships have fostered a rich environment for innovation and exploration in the realm of calcium-based solutions.

Conclusion

Baek Il Kim exemplifies the spirit of innovation in the biotechnology field. His patented method for stabilizing calcium phosphate solutions represents a significant advancement that may enhance the formulation of various calcium-containing products. As he continues his work at Bioalpha Corporation, the potential for further innovations and contributions to the industry remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…